Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 1
2011 3
2012 8
2013 11
2014 20
2015 31
2016 25
2017 26
2018 29
2019 24
2020 34
2021 25
2022 24
2023 18
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

242 results

Results by year

Filters applied: . Clear all
Page 1
Childhood and Adolescent Relapsed/Refractory Aggressive B-Cell Lymphomas With t(8;14) and BCL2 Expression, Burkitt Lymphoma Versus Diffuse Large B-Cell Lymphoma: A Diagnostic Challenge.
El Dana F, Garces Narvaez SA, El-Mallawany NK, Agrusa JE, Dreyer ZE, Marcogliese AN, Elghetany MT, Punia JN, Ok CY, Patel KP, Lopez-Terrada DH, Fisher KE, Curry CV. El Dana F, et al. Among authors: patel kp. Pediatr Dev Pathol. 2024 Mar 11:10935266241230600. doi: 10.1177/10935266241230600. Online ahead of print. Pediatr Dev Pathol. 2024. PMID: 38468555 Free article.
Outcome of Patients With Relapsed Acute Promyelocytic Leukemia.
Sasaki K, Ravandi F, Kadia T, DiNardo CD, Yilmaz M, Short N, Jabbour E, Patel KP, Loghavi S, Pierce S, Borthakur G, Kantarjian H. Sasaki K, et al. Among authors: patel kp. Clin Lymphoma Myeloma Leuk. 2024 Feb 3:S2152-2650(24)00059-4. doi: 10.1016/j.clml.2024.01.015. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38431521
Limited Independent Follow-Up with Germline Testing of Variants Detected in BRCA1 and BRCA2 by Tumor-Only Sequencing.
Nowlen CJ, Daniels M, Uzunparmak B, Ileana Dumbrava EE, Yuan Y, Patel KP, Rayes N, Harkenrider J, Wathoo C, Veazie J, Luna KA, Wang W, Horombe C, Javle M, Ahnert JR, Yap TA, Arun B, Lu KH, Meric-Bernstam F. Nowlen CJ, et al. Among authors: patel kp. J Immunother Precis Oncol. 2024 Feb 5;7(1):7-17. doi: 10.36401/JIPO-23-2. eCollection 2024 Feb. J Immunother Precis Oncol. 2024. PMID: 38327755 Free PMC article.
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AML.
Short NJ, Daver N, Dinardo CD, Kadia T, Nasr LF, Macaron W, Yilmaz M, Borthakur G, Montalban-Bravo G, Garcia-Manero G, Issa GC, Chien KS, Jabbour E, Nasnas C, Huang X, Qiao W, Matthews J, Stojanik CJ, Patel KP, Abramova R, Thankachan J, Konopleva M, Kantarjian H, Ravandi F. Short NJ, et al. Among authors: patel kp. J Clin Oncol. 2024 May 1;42(13):1499-1508. doi: 10.1200/JCO.23.01911. Epub 2024 Jan 26. J Clin Oncol. 2024. PMID: 38277619 Clinical Trial.
Predictive and prognostic molecular biomarkers in lymphomas.
Iorgulescu JB, Medeiros LJ, Patel KP. Iorgulescu JB, et al. Among authors: patel kp. Pathology. 2024 Mar;56(2):239-258. doi: 10.1016/j.pathol.2023.12.001. Epub 2023 Dec 19. Pathology. 2024. PMID: 38216400 Review.
Intragenic EGFR::EGFR.E1E8 Fusion (EGFRvIII) in 4331 Solid Tumors.
Zheng L, Luthra R, Alvarez HA, San Lucas FA, Duose DY, Wistuba II, Fuller GN, Ballester LY, Roy-Chowdhuri S, Sweeney KJ, Rashid A, Yang RK, Chen W, Liu A, Wu Y, Albarracin C, Patel KP, Routbort MJ, Sahin AA, Ding Q, Chen H. Zheng L, et al. Among authors: patel kp. Cancers (Basel). 2023 Dec 19;16(1):6. doi: 10.3390/cancers16010006. Cancers (Basel). 2023. PMID: 38201434 Free PMC article.
Corrigendum to "Epstein-Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship." [Modern Pathology 34 (2021) 2154-2167].
Medeiros LJ, Marques-Piubelli ML, Sangiorgio VFI, Ruiz-Cordero R, Vega F, Feldman AL, Chapman JR, Clemens MW, Hunt KK, Evans MG, Khoo C, Lade S, Silberman M, Morkowski J, Pina EM, Mills DC, Bates CM, Magno WB, Sohani AR, Sieling BA, O'Donoghue JM, Bacon CM, Patani N, Televantou D, Turner SD, Johnson L, MacNeill F, Wotherspoon AC, Iyer SP, Malpica LE, Patel KP, Xu J, Miranda RN. Medeiros LJ, et al. Among authors: patel kp. Mod Pathol. 2023 Dec;36(12):100355. doi: 10.1016/j.modpat.2023.100355. Epub 2023 Nov 9. Mod Pathol. 2023. PMID: 37948938 No abstract available.
Detection of clinically actionable gene fusions by next-generation sequencing-based RNA sequencing of non-small cell lung cancer cytology specimens: A single-center experience with comparison to fluorescence in situ hybridization.
Diks J, Tang Z, Altan M, Anderson S, Chen H, Rashid A, Yang RK, Routbort MJ, Patel KP, Toruner GA, Medeiros LJ, Tang G, Luthra R, Roy-Chowdhuri S. Diks J, et al. Among authors: patel kp. Cancer Cytopathol. 2024 Jan;132(1):41-49. doi: 10.1002/cncy.22766. Epub 2023 Sep 25. Cancer Cytopathol. 2024. PMID: 37747438
Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants.
Bataller A, Loghavi S, Gerstein Y, Bazinet A, Sasaki K, Chien KS, Hammond D, Montalban-Bravo G, Borthakur G, Short N, Issa GC, Kadia TM, Daver N, Tang G, Quesada A, Patel KP, Ravandi F, Fiskus W, Mill CP, Kantarjian HM, Bhalla K, Garcia-Manero G, Oran B, DiNardo CD. Bataller A, et al. Among authors: patel kp. Am J Hematol. 2023 Nov;98(11):1780-1790. doi: 10.1002/ajh.27070. Epub 2023 Sep 4. Am J Hematol. 2023. PMID: 37665752
242 results